How the material is made, and how a supplier is qualified
Lyze Labs is the manufacturer of record. Synthesis, purification, lyophilisation, filling and batch release run under our own quality system, to GMP, and our own quality control laboratory decides release. Every released batch is then confirmed by an independent laboratory before it ships, so the number on the certificate is never only our own.
The purity figure on a certificate is decided during purification, long before anything is measured. That is why how material is made matters as much as how it is tested, and why supplier qualification is the part of this business that does the most work.
Where responsibility sits
Ours
- Manufacture: synthesis, purification, lyophilisation and filling
- The specification every compound is made and judged against
- In-house quality control and the batch release decision
- The quality system: procedures, change control, CAPA, recall
- Publication of every certificate, and the order record
Deliberately not ours
- The confirming laboratory, independent by design so the result is not ours to influence
- The accreditation behind it, granted to that laboratory by an accreditation body
- Any regulatory approval: this is research material, not a medicine
How a research peptide is made
Solid-phase synthesis
The peptide chain is assembled one residue at a time on a solid resin support, with the growing chain anchored while each new amino acid is coupled and deprotected in turn. Almost every synthetic peptide in the catalogue is built this way. The errors that matter start here: a coupling that does not go to completion leaves a deletion sequence one residue short, and that impurity carries all the way through to the certificate.
Cleavage and deprotection
The finished chain is cleaved from the resin and its side-chain protecting groups are removed. This step generates most of the small-molecule debris that purification then has to take out, and it is where residual solvent and counter-ion first enter the material.
Purification
Crude material is purified by preparative reversed-phase chromatography, collecting the fraction containing the target and discarding the deletion sequences, truncations and oxidised forms either side of it. The purity figure that eventually appears on a certificate is decided here, not at the testing stage. Testing measures it; purification determines it.
Lyophilisation
Purified material is freeze-dried to a solid. Removing water is what makes a peptide stable for long-term storage, which is why water content is a routine determination rather than an optional extra. A poorly dried cake looks the same and stores far worse.
Fill, seal and label
Material is filled into vials, sealed, and labelled with a lot identifier that resolves back to the source batch. This is the point at which an analysed quantity becomes the individual vial you receive, and it is the link the whole traceability chain depends on.
How a supplier is qualified
This is the part almost no vendor publishes, and it is the part that decides everything downstream.
A sample first, never an order first
A prospective supplier is assessed on material, not on a catalogue or a price list. Material is obtained and analysed before any commitment is made, because everything a supplier says about itself is cheaper to produce than the compound it is describing.
The certificate has to match the batch that was sent
This is the test that actually separates suppliers, and most of them fail it. A supplier presenting a certificate that does not correspond to the batch in the parcel has given you a document about somebody else's material. A generic product certificate, a certificate with no batch identifier, or a certificate whose batch does not match the vials is disqualifying on its own, regardless of the numbers on it.
Independent analysis, not the supplier's paperwork
The supplier's own certificate is treated as a claim to be checked, not as evidence. Independent analysis of the material decides whether the claim held. A supplier whose own figures survive independent analysis has told the truth once, which is the minimum, not the end of the assessment.
Qualification does not carry forward
Passing once qualifies a supplier to send a first batch. It does not release the second one. Every batch is analysed on arrival regardless of how the previous batch performed, because the failure mode in this market is a good first shipment followed by a worse second one.
A change of source is a change of product
When a compound moves to a different source it gets a new batch identifier, new analysis and a new certificate. The previous certificate is not carried over and the previous purity figure is not reused, because they describe material from somewhere else.
Common questions
Does Lyze Labs manufacture its own peptides?
Yes. Lyze Labs is the manufacturer of record. Synthesis, purification, lyophilisation, filling and batch release are carried out under our own quality system, and our own quality control laboratory decides whether a batch is released. What we deliberately do not do is rely on that alone: every released batch is also confirmed by an independent laboratory with no commercial interest in the result, and both sets of results are published on the batch certificate. A manufacturer that tests only its own material has no independent check anywhere in the chain, which is the gap this arrangement closes.
How are peptide suppliers qualified?
By analysing their material before committing to it, and by requiring that the certificate they present corresponds to the batch actually shipped. A batch-matched certificate is the deciding test. Suppliers routinely present certificates that are generic to a product, carry no batch identifier, or refer to a different lot than the one in the parcel, and any of those is disqualifying on its own no matter how good the reported numbers are.
Is the material pharmaceutical grade or GMP manufactured?
Manufacturing runs to Good Manufacturing Practice and the quality system to ISO 9001, with confirmatory analysis at an ISO/IEC 17025 accredited laboratory. What that does not do is make the material a medicine: it is supplied as a research reference standard, it is not approved by any regulator for human use, and it is not sold for that purpose. Alongside the standards, the analytical evidence for each batch is published in full: the certificate, the methods behind every number, and the specification each result was judged against.
Why does the purity change between batches of the same compound?
Because purity is a property of a batch, not of a product. Each synthesis and purification run performs slightly differently, and the certificate reports what that particular run achieved. A vendor whose purity figure never moves between batches is either publishing the same certificate repeatedly or reporting a target rather than a measurement.
The rest of the evidence
Each page answers one part of the same question. None of them asks you to take a claim on trust.
The procedures that decide whether a batch is released, held or withdrawn.
Every technique on the certificates, what it proves, and what it cannot.
Field by field, plus the red flags that tell you a certificate is worthless.
How the vial in your hand connects back to the batch that was tested.
Published storage conditions, shelf life, and what degrades material fastest.
For research and laboratory use only. All Lyze Labs compounds are supplied as research reference material, not for human or veterinary use, and are not approved by any regulator for human use.